Falls During a 10-week Placebo-Controlled Study of Droxidopa for Neurogenic Orthostatic Hypotension in Parkinson's Disease

被引：0
|
作者：
Rowse, G. [1 ]
Heritier, S. [2 ]
Hewitt, L. [1 ]
机构：
[1] Lundbeck LLC, Deerfield, IL USA
[2] Monash Univ, Melbourne, Vic 3004, Australia
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2015年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
A40
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [31] A placebo-controlled 10-week prospective comparison of the occurrence of falls in dementia: Olanzapine vs. risperidone
    Kennedy, JS
    Young, C
    Hoffmann-Poole, V
    Deberdt, W
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) : 1069 - 1069
  • [32] Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus
    Steven Vernino
    Daniel Claassen
    Clinical Autonomic Research, 2017, 27 : 33 - 34
  • [33] Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus
    Vernino, Steven
    Claassen, Daniel
    CLINICAL AUTONOMIC RESEARCH, 2017, 27 : S33 - S34
  • [34] Lithium Trial in Alzheimer's Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study
    Hampel, Harald
    Ewers, Michael
    Buerger, Katharina
    Annas, Peter
    Moertberg, Anette
    Bogstedt, Anna
    Froelich, Lutz
    Schroeder, Johannes
    Schoenknecht, Peter
    Riepe, Matthias W.
    Kraft, Inga
    Gasser, Thomas
    Leyhe, Thomas
    Moeller, Hans-Juergen
    Kurz, Alexander
    Basun, Hans
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (06) : 922 - 931
  • [35] Droxidopa for the Short-Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (nOH306B)
    Hauser, Robert A.
    Isaacson, Stuart
    Lisk, Jerome P.
    Hewitt, L. Arthur
    Rowse, Gerry
    MOVEMENT DISORDERS, 2015, 30 (05) : 646 - 654
  • [36] Droxidopa Treatment Impact on Orthostatic Symptoms and Standing Systolic Blood Pressure in Patients with Parkinson's Disease (PD) and Symptomatic Neurogenic Orthostatic Hypotension (NOH)
    Isaacson, Stuart
    Hauser, Robert
    Szakacs, Cameron
    Cioffi, Christopher
    NEUROLOGY, 2013, 80 (19) : E203 - E203
  • [37] Treatment of Orthostatic Hypotension Due to Autonomic Dysfunction (Neurogenic Orthostatic Hypotension) in a Patient with Cardiovascular Disease and Parkinson's Disease
    McCullough, Peter A.
    CARDIOLOGY AND THERAPY, 2019, 8 (01) : 145 - 150
  • [38] Treatment of Orthostatic Hypotension Due to Autonomic Dysfunction (Neurogenic Orthostatic Hypotension) in a Patient with Cardiovascular Disease and Parkinson's Disease
    Peter A. McCullough
    Cardiology and Therapy, 2019, 8 : 145 - 150
  • [39] Treatment of Neurogenic Orthostatic Hypotension with Droxidopa: Results from a Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Induction Design Study
    Kaufmann, Horacio
    Freeman, Roy
    Biaggioni, Italo
    Low, Phillip
    Pedder, Simon
    Hewitt, Arthur
    Mathias, Christopher
    NEUROLOGY, 2012, 78
  • [40] Patient-Reported "Good" Days During a Prospective Study of the Treatment of Neurogenic Orthostatic Hypotension With Droxidopa
    Kymes, Steven
    Hewitt, Lawrence
    Francois, Clement
    NEUROLOGY, 2020, 94 (15)
12345